Carisma Therapeutics, formerly Carma Therapeutics, is working on a new onco-immunotherapy approach for treating cancer patients with solid tumors.
{iframe}https://www.bizjournals.com/philadelphia/news/2018/06/27/penn-cell-therapy-spinoff-closes-53m-financing.html?ana=e_phil_bn_breakingnews&u=wjGEy67ABoSnsLErlc5ry0j5hx3&t=1530538100&j=82388541{/iframe}